LY09004

· Luye Pharma Group Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY09004, covering 2020-10-01 to 2020-10-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD） [Phase 3]